![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:DOK5-SLC2A1 (FusionGDB2 ID:HG55816TG6513) |
Fusion Gene Summary for DOK5-SLC2A1 |
![]() |
Fusion gene information | Fusion gene name: DOK5-SLC2A1 | Fusion gene ID: hg55816tg6513 | Hgene | Tgene | Gene symbol | DOK5 | SLC2A1 | Gene ID | 55816 | 6513 |
Gene name | docking protein 5 | solute carrier family 2 member 1 | |
Synonyms | C20orf180|IRS-6|IRS6 | CSE|DYT17|DYT18|DYT9|EIG12|GLUT|GLUT-1|GLUT1|GLUT1DS|HTLVR|PED|SDCHCN | |
Cytomap | ('DOK5')('SLC2A1') 20q13.2 | 1p34.2 | |
Type of gene | protein-coding | protein-coding | |
Description | docking protein 5downstream of tyrosine kinase 5insulin receptor substrate 6 | solute carrier family 2, facilitated glucose transporter member 1choreoathetosis/spasticity, episodic (paroxysmal choreoathetosis/spasticity)glucose transporter type 1, erythrocyte/brainhepG2 glucose transporterhuman T-cell leukemia virus (I and II) r | |
Modification date | 20200320 | 20200322 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000491469, ENST00000262593, ENST00000395939, | ||
Fusion gene scores | * DoF score | 6 X 3 X 3=54 | 7 X 6 X 4=168 |
# samples | 8 | 7 | |
** MAII score | log2(8/54*10)=0.567040592723894 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/168*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: DOK5 [Title/Abstract] AND SLC2A1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | DOK5(53092551)-SLC2A1(43408992), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | DOK5-SLC2A1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. DOK5-SLC2A1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. DOK5-SLC2A1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. DOK5-SLC2A1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | SLC2A1 | GO:0065003 | protein-containing complex assembly | 18347014 |
Tgene | SLC2A1 | GO:1904659 | glucose transmembrane transport | 2211693|18245775|25982116|27078104 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | OV | TCGA-29-1781-01A | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
Top |
Fusion Gene ORF analysis for DOK5-SLC2A1 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000491469 | ENST00000426263 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
3UTR-intron | ENST00000491469 | ENST00000372500 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
3UTR-intron | ENST00000491469 | ENST00000415851 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
3UTR-intron | ENST00000491469 | ENST00000475162 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
5CDS-intron | ENST00000262593 | ENST00000372500 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
5CDS-intron | ENST00000262593 | ENST00000415851 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
5CDS-intron | ENST00000262593 | ENST00000475162 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
In-frame | ENST00000262593 | ENST00000426263 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
intron-3CDS | ENST00000395939 | ENST00000426263 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
intron-intron | ENST00000395939 | ENST00000372500 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
intron-intron | ENST00000395939 | ENST00000415851 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
intron-intron | ENST00000395939 | ENST00000475162 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000262593 | DOK5 | chr20 | 53092551 | + | ENST00000426263 | SLC2A1 | chr1 | 43408992 | - | 3537 | 416 | 341 | 1876 | 511 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000262593 | ENST00000426263 | DOK5 | chr20 | 53092551 | + | SLC2A1 | chr1 | 43408992 | - | 0.006619349 | 0.99338067 |
Top |
Fusion Genomic Features for DOK5-SLC2A1 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
![]() |
![]() |
Top |
Fusion Protein Features for DOK5-SLC2A1 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr20:53092551/chr1:43408992) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 282_288 | 6 | 493.0 | Region | Monosaccharide binding | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 468_492 | 6 | 493.0 | Region | Disordered region | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 113_120 | 6 | 493.0 | Topological domain | Extracellular | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 145_155 | 6 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 177_185 | 6 | 493.0 | Topological domain | Extracellular | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 207_271 | 6 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 294_306 | 6 | 493.0 | Topological domain | Extracellular | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 329_334 | 6 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 34_66 | 6 | 493.0 | Topological domain | Extracellular | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 356_365 | 6 | 493.0 | Topological domain | Extracellular | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 389_401 | 6 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 423_429 | 6 | 493.0 | Topological domain | Extracellular | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 451_492 | 6 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 88_90 | 6 | 493.0 | Topological domain | Cytoplasmic | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 121_144 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D4 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 12_33 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D1 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 156_176 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D5 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 186_206 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D6 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 272_293 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D7 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 307_328 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D8 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 335_355 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D9 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 366_388 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D10 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 402_422 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D11 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 430_450 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D12 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 67_87 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D2 | |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 91_112 | 6 | 493.0 | Transmembrane | Note=Helical%3B Name%3D3 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | DOK5 | chr20:53092551 | chr1:43408992 | ENST00000262593 | + | 1 | 8 | 132_237 | 22 | 307.0 | Domain | IRS-type PTB |
Hgene | DOK5 | chr20:53092551 | chr1:43408992 | ENST00000262593 | + | 1 | 8 | 8_112 | 22 | 307.0 | Domain | Note=PH |
Hgene | DOK5 | chr20:53092551 | chr1:43408992 | ENST00000395939 | + | 1 | 8 | 132_237 | 0 | 199.0 | Domain | IRS-type PTB |
Hgene | DOK5 | chr20:53092551 | chr1:43408992 | ENST00000395939 | + | 1 | 8 | 8_112 | 0 | 199.0 | Domain | Note=PH |
Hgene | DOK5 | chr20:53092551 | chr1:43408992 | ENST00000262593 | + | 1 | 8 | 263_273 | 22 | 307.0 | Motif | Note=DKFBH motif |
Hgene | DOK5 | chr20:53092551 | chr1:43408992 | ENST00000395939 | + | 1 | 8 | 263_273 | 0 | 199.0 | Motif | Note=DKFBH motif |
Tgene | SLC2A1 | chr20:53092551 | chr1:43408992 | ENST00000426263 | 0 | 10 | 1_11 | 6 | 493.0 | Topological domain | Cytoplasmic |
Top |
Fusion Gene Sequence for DOK5-SLC2A1 |
![]() |
>23866_23866_1_DOK5-SLC2A1_DOK5_chr20_53092551_ENST00000262593_SLC2A1_chr1_43408992_ENST00000426263_length(transcript)=3537nt_BP=416nt TTCTCCTCCTTCTCGGCCGGGAGGAGGCAGGGCTGGATCCCTCAGCCGCCGCCGCTCCTCCTCCTGGCAGGCCGGCCGCGGAGTCAGCTG ACGCCGGCGCTCCAGCCTCGCCTCCCCGCGCCGCGCTCTGCGCTCCCCGAAAGTGGCTGCAAGCCGGCCGCCCACTGTCAGGGTTGGGGG GACAGAGAAAGTGATGTGCGCCTTCTAAAGCCTCGCCCAGCGCCGCCGAAGCAGCTTCACCTCTCCAACTTTCTCCCACCGACTGCTTGT CTTGACCCTGCCCTCCACCCTCCCCAGAGCCACTTCGGGTGCGCGCTCTTGGGTAAAGGGGGGGTCACCGGCTGTCTGGGATGGCTTCCA ATTTTAATGACATAGTGAAGCAAGGGTACGTGAGGATCCGGAGCAGACGCCTCGGGAAGCTGACGGGTCGCCTCATGCTGGCCGTGGGAG GAGCAGTGCTTGGCTCCCTGCAGTTTGGCTACAACACTGGAGTCATCAATGCCCCCCAGAAGGTGATCGAGGAGTTCTACAACCAGACAT GGGTCCACCGCTATGGGGAGAGCATCCTGCCCACCACGCTCACCACGCTCTGGTCCCTCTCAGTGGCCATCTTTTCTGTTGGGGGCATGA TTGGCTCCTTCTCTGTGGGCCTTTTCGTTAACCGCTTTGGCCGGCGGAATTCAATGCTGATGATGAACCTGCTGGCCTTCGTGTCCGCCG TGCTCATGGGCTTCTCGAAACTGGGCAAGTCCTTTGAGATGCTGATCCTGGGCCGCTTCATCATCGGTGTGTACTGCGGCCTGACCACAG GCTTCGTGCCCATGTATGTGGGTGAAGTGTCACCCACAGCCCTTCGTGGGGCCCTGGGCACCCTGCACCAGCTGGGCATCGTCGTCGGCA TCCTCATCGCCCAGGTGTTCGGCCTGGACTCCATCATGGGCAACAAGGACCTGTGGCCCCTGCTGCTGAGCATCATCTTCATCCCGGCCC TGCTGCAGTGCATCGTGCTGCCCTTCTGCCCCGAGAGTCCCCGCTTCCTGCTCATCAACCGCAACGAGGAGAACCGGGCCAAGAGTGTGC TAAAGAAGCTGCGCGGGACAGCTGACGTGACCCATGACCTGCAGGAGATGAAGGAAGAGAGTCGGCAGATGATGCGGGAGAAGAAGGTCA CCATCCTGGAGCTGTTCCGCTCCCCCGCCTACCGCCAGCCCATCCTCATCGCTGTGGTGCTGCAGCTGTCCCAGCAGCTGTCTGGCATCA ACGCTGTCTTCTATTACTCCACGAGCATCTTCGAGAAGGCGGGGGTGCAGCAGCCTGTGTATGCCACCATTGGCTCCGGTATCGTCAACA CGGCCTTCACTGTCGTGTCGCTGTTTGTGGTGGAGCGAGCAGGCCGGCGGACCCTGCACCTCATAGGCCTCGCTGGCATGGCGGGTTGTG CCATACTCATGACCATCGCGCTAGCACTGCTGGAGCAGCTACCCTGGATGTCCTATCTGAGCATCGTGGCCATCTTTGGCTTTGTGGCCT TCTTTGAAGTGGGTCCTGGCCCCATCCCATGGTTCATCGTGGCTGAACTCTTCAGCCAGGGTCCACGTCCAGCTGCCATTGCCGTTGCAG GCTTCTCCAACTGGACCTCAAATTTCATTGTGGGCATGTGCTTCCAGTATGTGGAGCAACTGTGTGGTCCCTACGTCTTCATCATCTTCA CTGTGCTCCTGGTTCTGTTCTTCATCTTCACCTACTTCAAAGTTCCTGAGACTAAAGGCCGGACCTTCGATGAGATCGCTTCCGGCTTCC GGCAGGGGGGAGCCAGCCAAAGTGACAAGACACCCGAGGAGCTGTTCCATCCCCTGGGGGCTGATTCCCAAGTGTGAGTCGCCCCAGATC ACCAGCCCGGCCTGCTCCCAGCAGCCCTAAGGATCTCTCAGGAGCACAGGCAGCTGGATGAGACTTCCAAACCTGACAGATGTCAGCCGA GCCGGGCCTGGGGCTCCTTTCTCCAGCCAGCAATGATGTCCAGAAGAATATTCAGGACTTAACGGCTCCAGGATTTTAACAAAAGCAAGA CTGTTGCTCAAATCTATTCAGACAAGCAACAGGTTTTATAATTTTTTTATTACTGATTTTGTTATTTTTATATCAGCCTGAGTCTCCTGT GCCCACATCCCAGGCTTCACCCTGAATGGTTCCATGCCTGAGGGTGGAGACTAAGCCCTGTCGAGACACTTGCCTTCTTCACCCAGCTAA TCTGTAGGGCTGGACCTATGTCCTAAGGACACACTAATCGAACTATGAACTACAAAGCTTCTATCCCAGGAGGTGGCTATGGCCACCCGT TCTGCTGGCCTGGATCTCCCCACTCTAGGGGTCAGGCTCCATTAGGATTTGCCCCTTCCCATCTCTTCCTACCCAACCACTCAAATTAAT CTTTCTTTACCTGAGACCAGTTGGGAGCACTGGAGTGCAGGGAGGAGAGGGGAAGGGCCAGTCTGGGCTGCCGGGTTCTAGTCTCCTTTG CACTGAGGGCCACACTATTACCATGAGAAGAGGGCCTGTGGGAGCCTGCAAACTCACTGCTCAAGAAGACATGGAGACTCCTGCCCTGTT GTGTATAGATGCAAGATATTTATATATATTTTTGGTTGTCAATATTAAATACAGACACTAAGTTATAGTATATCTGGACAAGCCAACTTG TAAATACACCACCTCACTCCTGTTACTTACCTAAACAGATATAAATGGCTGGTTTTTAGAAACATGGTTTTGAAATGCTTGTGGATTGAG GGTAGGAGGTTTGGATGGGAGTGAGACAGAAGTAAGTGGGGTTGCAACCACTGCAACGGCTTAGACTTCGACTCAGGATCCAGTCCCTTA CACGTACCTCTCATCAGTGTCCTCTTGCTCAAAAATCTGTTTGATCCCTGTTACCCAGAGAATATATACATTCTTTATCTTGACATTCAA GGCATTTCTATCACATATTTGATAGTTGGTGTTCAAAAAAACACTAGTTTTGTGCCAGCCGTGATGCTCAGGCTTGAAATGCATTATTTT GAATGTGAAGTAAATACTGTACCTTTATTGGACAGGCTCAAAGAGGTTATGTGCCTGAAGTCGCACAGTGAATAAGCTAAAACACCTGCT TTTAACAATGGTACCATACAACCACTACTCCATTAACTCCACCCACCTCCTGCACCCCTCCCCACACACACAAAATGAACCACGTTCTTT GTATGGGCCCAATGAGCTGTCAAGCTGCCCTGTGTTCATTTCATTTGGAATTGCCCCCTCTGGTTCCTCTGTATACTACTGCTTCATCTC TAAAGACAGCTCATCCTCCTCCTTCACCCCTGAATTTCCAGAGCACTTCATCTGCTCCTTCATCACAAGTCCAGTTTTCTGCCACTAGTC TGAATTTCATGAGAAGATGCCGATTTGGTTCCTGTGGGTCCTCAGCACTATTCAGTACAGTGCTTGATGCACAGCAGGCACTCAGAAAAT ACTGGAGGAAATAAAACACCAAAGATA >23866_23866_1_DOK5-SLC2A1_DOK5_chr20_53092551_ENST00000262593_SLC2A1_chr1_43408992_ENST00000426263_length(amino acids)=511AA_BP=25 MSGMASNFNDIVKQGYVRIRSRRLGKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAI FSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQ LGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQM MREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGL AGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGP YVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for DOK5-SLC2A1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for DOK5-SLC2A1 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for DOK5-SLC2A1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | DOK5 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Tgene | C4551966 | GLUT1 DEFICIENCY SYNDROME 1 | 25 | CLINGEN;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C1842534 | DYSTONIA 18 (disorder) | 15 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C1847501 | Glut1 Deficiency Syndrome | 12 | CLINGEN;CTD_human;ORPHANET | |
Tgene | C3149117 | GLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE | 8 | CLINGEN | |
Tgene | C3553859 | EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12 | 6 | GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0036572 | Seizures | 4 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C0008073 | Developmental Disabilities | 3 | CTD_human | |
Tgene | C0013421 | Dystonia | 3 | GENOMICS_ENGLAND | |
Tgene | C0022333 | Jacksonian Seizure | 3 | CTD_human | |
Tgene | C0085996 | Child Development Deviations | 3 | CTD_human | |
Tgene | C0085997 | Child Development Disorders, Specific | 3 | CTD_human | |
Tgene | C0149958 | Complex partial seizures | 3 | CTD_human | |
Tgene | C0234533 | Generalized seizures | 3 | CTD_human | |
Tgene | C0234535 | Clonic Seizures | 3 | CTD_human | |
Tgene | C0270824 | Visual seizure | 3 | CTD_human | |
Tgene | C0270844 | Tonic Seizures | 3 | CTD_human | |
Tgene | C0270846 | Epileptic drop attack | 3 | CTD_human | |
Tgene | C0422850 | Seizures, Somatosensory | 3 | CTD_human | |
Tgene | C0422852 | Seizures, Auditory | 3 | CTD_human | |
Tgene | C0422853 | Olfactory seizure | 3 | CTD_human | |
Tgene | C0422854 | Gustatory seizure | 3 | CTD_human | |
Tgene | C0422855 | Vertiginous seizure | 3 | CTD_human | |
Tgene | C0494475 | Tonic - clonic seizures | 3 | CTD_human | |
Tgene | C0751056 | Non-epileptic convulsion | 3 | CTD_human | |
Tgene | C0751110 | Single Seizure | 3 | CTD_human | |
Tgene | C0751123 | Atonic Absence Seizures | 3 | CTD_human | |
Tgene | C0751494 | Convulsive Seizures | 3 | CTD_human | |
Tgene | C0751495 | Seizures, Focal | 3 | CTD_human | |
Tgene | C0751496 | Seizures, Sensory | 3 | CTD_human | |
Tgene | C1832855 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C1837206 | Cryohydrocytosis, Stomatin-Deficient, with Mental Retardation, Seizures, Cataracts, and Massive Hepatosplenomegaly | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C3495874 | Nonepileptic Seizures | 3 | CTD_human | |
Tgene | C4048158 | Convulsions | 3 | CTD_human | |
Tgene | C4316903 | Absence Seizures | 3 | CTD_human | |
Tgene | C4317109 | Epileptic Seizures | 3 | CTD_human | |
Tgene | C4317123 | Myoclonic Seizures | 3 | CTD_human | |
Tgene | C4505436 | Generalized Absence Seizures | 3 | CTD_human | |
Tgene | C0025958 | Microcephaly | 2 | CTD_human | |
Tgene | C0270850 | Idiopathic generalized epilepsy | 2 | GENOMICS_ENGLAND | |
Tgene | C0272048 | stomatocytic anemia | 2 | GENOMICS_ENGLAND | |
Tgene | C0677598 | Stomatocytosis Result | 2 | GENOMICS_ENGLAND | |
Tgene | C1838604 | EPILEPSY, CHILDHOOD ABSENCE, 1 | 2 | ORPHANET | |
Tgene | C1956147 | Microlissencephaly | 2 | CTD_human | |
Tgene | C3714756 | Intellectual Disability | 2 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C3853041 | Severe Congenital Microcephaly | 2 | CTD_human | |
Tgene | C0004134 | Ataxia | 1 | CTD_human | |
Tgene | C0004138 | Ataxias, Hereditary | 1 | GENOMICS_ENGLAND | |
Tgene | C0006142 | Malignant neoplasm of breast | 1 | CTD_human | |
Tgene | C0007102 | Malignant tumor of colon | 1 | CTD_human | |
Tgene | C0007124 | Noninfiltrating Intraductal Carcinoma | 1 | CTD_human | |
Tgene | C0007134 | Renal Cell Carcinoma | 1 | CTD_human | |
Tgene | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human | |
Tgene | C0009375 | Colonic Neoplasms | 1 | CTD_human | |
Tgene | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human | |
Tgene | C0020796 | Profound Mental Retardation | 1 | CTD_human | |
Tgene | C0023903 | Liver neoplasms | 1 | CTD_human | |
Tgene | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human | |
Tgene | C0025521 | Inborn Errors of Metabolism | 1 | CTD_human | |
Tgene | C0027125 | Myotonia | 1 | GENOMICS_ENGLAND | |
Tgene | C0027765 | nervous system disorder | 1 | CTD_human | |
Tgene | C0029408 | Degenerative polyarthritis | 1 | CTD_human | |
Tgene | C0031149 | Peritoneal Neoplasms | 1 | CTD_human | |
Tgene | C0037772 | Spastic Paraplegia | 1 | GENOMICS_ENGLAND | |
Tgene | C0086543 | Cataract | 1 | GENOMICS_ENGLAND | |
Tgene | C0086743 | Osteoarthrosis Deformans | 1 | CTD_human | |
Tgene | C0240991 | Ataxia, Sensory | 1 | CTD_human | |
Tgene | C0278161 | Ataxia, Motor | 1 | CTD_human | |
Tgene | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 1 | CTD_human | |
Tgene | C0345904 | Malignant neoplasm of liver | 1 | CTD_human | |
Tgene | C0345967 | Malignant mesothelioma | 1 | CTD_human | |
Tgene | C0346990 | Carcinomatosis of peritoneal cavity | 1 | CTD_human | |
Tgene | C0424605 | Developmental delay (disorder) | 1 | GENOMICS_ENGLAND | |
Tgene | C0427190 | Ataxia, Truncal | 1 | CTD_human | |
Tgene | C0520966 | Abnormal coordination | 1 | CTD_human | |
Tgene | C0543888 | Epileptic encephalopathy | 1 | GENOMICS_ENGLAND | |
Tgene | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND | |
Tgene | C0678222 | Breast Carcinoma | 1 | CTD_human | |
Tgene | C0750937 | Ataxia, Appendicular | 1 | CTD_human | |
Tgene | C0750940 | Tremor, Rubral | 1 | CTD_human | |
Tgene | C0917816 | Mental deficiency | 1 | CTD_human | |
Tgene | C0919267 | ovarian neoplasm | 1 | CTD_human | |
Tgene | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human | |
Tgene | C1176475 | Ductal Carcinoma | 1 | CTD_human | |
Tgene | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human | |
Tgene | C1266042 | Chromophobe Renal Cell Carcinoma | 1 | CTD_human | |
Tgene | C1266043 | Sarcomatoid Renal Cell Carcinoma | 1 | CTD_human | |
Tgene | C1266044 | Collecting Duct Carcinoma of the Kidney | 1 | CTD_human | |
Tgene | C1306837 | Papillary Renal Cell Carcinoma | 1 | CTD_human | |
Tgene | C1332347 | Atypical Ductal Breast Hyperplasia | 1 | CTD_human | |
Tgene | C1458155 | Mammary Neoplasms | 1 | CTD_human | |
Tgene | C1851936 | Paroxysmal choreoathetosis | 1 | GENOMICS_ENGLAND | |
Tgene | C1869117 | Paroxysmal nonkinesigenic dyskinesia | 1 | GENOMICS_ENGLAND | |
Tgene | C2239176 | Liver carcinoma | 1 | CTD_human | |
Tgene | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |